Halaven (Eribulin)

eribulin mesilate 1 mg/2 mL injection, 2 mL vial · INJECTION · PBS code 10144X

STREAMLINED

What it costs

AU$162.45 PBS-determined price per pack

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2014-10-01.
• Repeats: 13.
• PBS program: IP.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Locally advanced or metastatic breast cancer

Patient must have progressive disease; AND

Patient must have failed at least two prior chemotherapeutic regimens for this condition; AND

The treatment must be the sole PBS-subsidised therapy for this condition.

Sponsor: Eisai Australia Pty Ltd ABN 73 117 970 993

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.